Showing results (401-410 of 460) with videos related to
Sort By:
Pageof 46
Mucosal Immunology|January 5, 2017
Enrichment of herpes simplex virus type 2 (HSV-2) reactive mucosal T cells in the human female genital tractC M Posavad, L Zhao, L Dong, et al.American Journal of Obstetrics and Gynecology|March 1, 1986
Etiology of cervical inflammationJ Paavonen, C W Critchlow, T DeRouen, et al.The Journal of Infectious Diseases|August 11, 1992
Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials NetworkB S Graham, R B Belshe, M L Clements, et al.The New England Journal of Medicine|October 15, 1987
Sexual practices, sexually transmitted diseases, and the incidence of anal cancerJ R Daling, N S Weiss, T G Hislop, et al.Antiviral Research|September 29, 2004
Introduction: Is viral shedding a surrogate marker for transmission of genital herpes?S L Sacks, P D Griffiths, L Corey, et al.Antiviral Research|September 29, 2004
Lessons from HIV and hepatitis virusesS L Sacks, P D Griffiths, L Corey, et al.Proceedings of the National Academy of Sciences of the United States of America|March 1, 1993
Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 proteinE L Cooney, M J McElrath, L Corey, et al.JAMA|April 27, 1984
Treatment of recurrent genital herpes simplex infections with oral acyclovir. A controlled trialR C Reichman, G J Badger, G J Mertz, et al.Pageof 46